CONMED Corp. (CNMD)
36.23
-0.38
(-1.04%)
USD |
NYSE |
May 19, 16:00
36.23
0.00 (0.00%)
After-Hours: 19:38
CONMED Research and Development Expense (Quarterly) : 16.33M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Escalon Medical Corp. | 0.0299M |
| IRIDEX Corp. | 0.949M |
| Stereotaxis, Inc. | 2.397M |
| Electromed, Inc. | 0.361M |
| Guided Therapeutics, Inc. | 0.045M |